| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Business Officer
1 company
Hicks Derek is an EVP, Chief Business Officer at Intellia Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $862K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2025 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Business Officer | Sell | 6,502 | $12.18 | $79,194.36 | -9.8% | -43.2% | -24.1% | |
| Jan 3, 2024 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Business Officer | Sell | 3,877 | $29.46 | $114,216.42 | -9.5% | -14.9% | -58.6% | |
| Jan 4, 2023 | NTLA Intellia Therapeutics, Inc. | EVP, Chief Business Officer | Sell | 1,812 | $37.21 | $67,424.52 | -9.5% | -7.5% | -24.6% |